PISANI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 79.469
AS - Asia 8.157
EU - Europa 5.965
SA - Sud America 1.184
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 15
Totale 94.905
Nazione #
US - Stati Uniti d'America 79.304
SG - Singapore 4.003
CN - Cina 1.509
UA - Ucraina 1.053
BR - Brasile 971
HK - Hong Kong 940
RU - Federazione Russa 919
DE - Germania 836
IE - Irlanda 815
IT - Italia 726
VN - Vietnam 530
KR - Corea 461
FR - Francia 386
SE - Svezia 317
GB - Regno Unito 311
FI - Finlandia 249
JP - Giappone 199
IN - India 104
CA - Canada 85
NL - Olanda 84
AR - Argentina 81
BD - Bangladesh 73
PL - Polonia 63
ID - Indonesia 55
MX - Messico 48
TR - Turchia 40
ES - Italia 37
IQ - Iraq 37
AT - Austria 31
EC - Ecuador 31
CL - Cile 28
BE - Belgio 27
EU - Europa 26
ZA - Sudafrica 24
CZ - Repubblica Ceca 19
KG - Kirghizistan 18
TH - Thailandia 18
PK - Pakistan 17
CO - Colombia 16
PY - Paraguay 16
VE - Venezuela 16
CH - Svizzera 15
JO - Giordania 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
AU - Australia 13
KE - Kenya 13
IR - Iran 12
PH - Filippine 12
LT - Lituania 11
SA - Arabia Saudita 11
MY - Malesia 10
RO - Romania 10
TN - Tunisia 10
AL - Albania 9
DZ - Algeria 9
IL - Israele 9
MA - Marocco 9
NP - Nepal 9
PE - Perù 8
PT - Portogallo 8
UY - Uruguay 8
AZ - Azerbaigian 7
EG - Egitto 7
KZ - Kazakistan 7
BO - Bolivia 6
GE - Georgia 6
GR - Grecia 6
OM - Oman 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
DM - Dominica 5
HN - Honduras 5
NG - Nigeria 5
DK - Danimarca 4
GT - Guatemala 4
LB - Libano 4
MT - Malta 4
RS - Serbia 4
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GY - Guiana 2
HR - Croazia 2
JM - Giamaica 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
Totale 94.884
Città #
Woodbridge 22.872
Wilmington 20.332
Houston 18.819
Fairfield 2.674
Singapore 1.981
Ann Arbor 1.796
Ashburn 1.485
Seattle 1.081
Chandler 1.005
Jacksonville 944
Hong Kong 927
Cambridge 914
San Jose 786
Dublin 758
Medford 547
Beijing 527
Dearborn 365
Santa Clara 337
The Dalles 285
New York 283
Lawrence 260
Rome 224
Los Angeles 198
Menlo Park 196
Tokyo 164
Moscow 162
Lauterbourg 160
Buffalo 154
Ho Chi Minh City 152
Zhengzhou 146
Hanoi 134
Council Bluffs 105
San Diego 98
São Paulo 96
Dallas 92
Mülheim 82
Milan 76
Munich 68
London 61
Nanjing 47
Norwalk 47
North Bergen 46
Mountain View 45
University Park 45
Shanghai 44
Rio de Janeiro 42
Hefei 41
Chicago 40
Helsinki 40
Orem 40
Redondo Beach 40
Falls Church 36
Guangzhou 35
Verona 35
Redwood City 34
Warsaw 34
Detroit 30
Kunming 30
Nuremberg 29
Mcallen 28
San Mateo 28
Atlanta 27
Brooklyn 27
Jakarta 27
Montreal 26
Saint Petersburg 26
Frankfurt am Main 25
Phoenix 25
Brussels 24
Columbus 24
Belo Horizonte 23
Palo Alto 23
Amsterdam 22
Da Nang 22
Redmond 22
Stockholm 22
Kraków 20
Monmouth Junction 20
Denver 19
Hangzhou 19
Mumbai 19
Toronto 19
Chennai 18
Manchester 18
San Francisco 18
Brno 17
Mexico City 17
Porto Alegre 17
Seoul 17
Brasília 15
Johannesburg 15
Salvador 15
Baghdad 14
Boardman 14
Campinas 14
Dhaka 14
Genoa 14
Haiphong 14
Vienna 14
Bangkok 13
Totale 82.941
Nome #
Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process 610
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 518
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 504
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 497
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 489
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 480
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 480
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 479
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia 479
Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice 476
Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: Implications for its antiepileptic activity 471
Muscarinic IPSPs in rat striatal cholinergic interneurones 471
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 471
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 469
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 467
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 465
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 465
Homeostatic changes of the endocannabinoid system in Parkinson's disease. 464
Distinct roles of group I mGlu receptors in striatal function 464
Abnormal plasticity in dystonia: Disruption of synaptic homeostasis 464
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 463
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 463
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 463
Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: Role of M1 muscarinic receptors 463
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum 462
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 460
Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia 460
Optogenetic stimulation reveals distinct modulatory properties of thalamostriatal vs corticostriatal glutamatergic inputs to fast-spiking interneurons 460
Early abnormalities in 123I-ioflupane (DaTSCAN) imaging in the fragile X-associated tremor ataxia syndrome (FXTAS): a case report 457
Synaptic transmission in the striatum: from plasticity to neurodegeneration 455
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 454
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 454
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons 451
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 450
Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro 450
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 449
Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit 447
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine 446
An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study 446
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 445
The Italian Dystonia Registry: rationale, design and preliminary findings 445
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 444
Re-emergence of striatal cholinergic interneurons in movement disorders 444
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 441
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 441
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 438
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 438
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 438
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. 438
Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: a case report 437
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 436
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine 436
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia 435
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 433
Synaptic plasticity in the ischaemic brain 432
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 432
Centrality of striatal cholinergic transmission in Basal Ganglia function 432
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine 431
Facial diplegia resembling bilateral Ramsay Hunt Syndrome 430
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 429
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity 429
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 429
Pisa syndrome in Parkinson disease: An observational multicenter Italian study 429
Hyperkinetic disorders and loss of synaptic downscaling 429
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 429
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 428
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 428
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1 427
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 427
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 427
Effects of two weeks of cerebellar theta burst stimulation in cervical dystonia patients 426
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 426
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 426
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 425
Double hit mouse model of Parkinson's disease 425
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity 424
Role of Ca2+ in striatal LTD and LTP 424
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 424
Morphological and functional study of dwarf neurons in the rat striatum 424
CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report 424
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 423
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 423
Outward potassium currents activated by depolarization in rat globus pallidus 423
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 422
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 422
Persistent chorea in DYT6, due to anticholinergic therapy 422
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 420
Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons 419
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 419
Engineering animal models of dystonia 418
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia 418
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 418
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices 418
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 415
Tissue plasminogen activator is required for corticostriatal long-term potentiation 415
Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin 415
Electrophysiology of 5-HT6 receptors 415
Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease 414
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment 414
Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-Dopa-Induced Dyskinesia 414
Totale 44.408
Categoria #
all - tutte 206.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 206.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021645 0 0 0 0 0 0 0 0 0 0 492 153
2021/20222.632 112 215 127 148 39 280 252 114 152 294 148 751
2022/20232.836 365 221 79 316 202 765 264 151 228 6 167 72
2023/2024983 108 34 66 20 89 234 39 110 66 21 4 192
2024/20256.039 147 1.447 643 321 155 430 370 226 485 484 769 562
2025/20267.900 694 446 1.095 685 728 264 1.027 1.183 959 803 16 0
Totale 95.710